Last reviewed · How we verify

NCT05065229: Ag-OS

A Study of Agreement Between Oxygen Saturation Measured by Two Probes in Infants on the Neonatal Unit

Completed NA Last updated 8 September 2023
What this trial tests

NA trial testing Oxygen saturation probe Mindray 520 N and Mindray 521 N in Neonatal Disease in 20 participants. Completed in 14 January 2023.

Timeline
15 July 2021
Primary endpoint
11 January 2023
14 January 2023

Quick facts

Lead sponsorUniversity of Nottingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposediagnostic
Enrollment20
Start date15 July 2021
Primary completion11 January 2023
Estimated completion14 January 2023
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Nottingham

Who can join

Adults 32 Weeks to 60 Weeks, any sex, with Neonatal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

On the neonatal unit in Derby, two types of probes are in routine use: Mindray 520 N and Mindray 521 N. Feedback from parents and staff show that there are concerns that the two probes given very different oxygen saturation readings and, often, do not agree with each other. This has raised concerns that infants' clinical care may be affected by the choice of probe. It is important to know if the two probes give similar results or not to ensure that infants get the appropriate monitoring and respiratory support as needed for good neonatal care. In this study, we will compare the reading made by the two probes and determine whether the readings of the two probes agree with each other and if any disagreement is such that clinical decision making is affected by the difference.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neonatal Disease

Currently open trials in the same condition.

Other University of Nottingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05065229.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing